| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/06/2005 | CN1634121A Dripping pills of ganoderma lucidum polysaccharide and polystictus versicolor polysaccharide |
| 07/06/2005 | CN1634120A Dripping pills of grifola umbellata polysaccharide |
| 07/06/2005 | CN1634099A Swerianmarin injectio, its preparation process and application |
| 07/06/2005 | CN1634095A Gynostemme pentaphylium soft capsule and its preparing process |
| 07/06/2005 | CN1634094A Pharmaceutical composition for protecting liver, preventing and treating liver cancer |
| 07/06/2005 | CN1634076A Rice bran sterol tablet for treating periodontal disease and its preparing process |
| 07/06/2005 | CN1634052A Omeprazole drop pills and its preparation method |
| 07/06/2005 | CN1634045A Compound famotidine chewing tablet preparation method |
| 07/06/2005 | CN1634038A Anethol trithione soft capsule and its preparation method |
| 07/06/2005 | CN1634036A Andrographolide soft capsule formulation and preparation method thereof |
| 07/06/2005 | CN1634032A Andrographolide preparation and its production method |
| 07/06/2005 | CN1634023A Chewing-gum for prevention and cure of stomatocace and tooth pain |
| 07/06/2005 | CN1634009A Colourless and transparent cigarette drop pills for healthcare |
| 07/06/2005 | CN1633999A Allicin microcapsule and its preparation method |
| 07/06/2005 | CN1633889A Liver protecting health food |
| 07/06/2005 | CN1209359C Novel dihydric indole compound, their preparation process and medicinal compositions containing them |
| 07/06/2005 | CN1209358C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 07/06/2005 | CN1209352C Hydrazine derivatives |
| 07/06/2005 | CN1209154C Novel preparation process of Qingkailing injection |
| 07/06/2005 | CN1209149C Collateral flow activating oil |
| 07/06/2005 | CN1209143C Pharmaceutical composition for treating hepatitis |
| 07/06/2005 | CN1209136C Medicine for treating halitosis |
| 07/06/2005 | CN1209131C Powder for lowering aminopherase of hepatitis B patients and its preparing process |
| 07/06/2005 | CN1209127C Application of yellowstem milkwort in preparing medicine for treating Meniere's Disease |
| 07/06/2005 | CN1209124C Chinese-herb composition and method for preparing same |
| 07/06/2005 | CN1209123C Chinese medicine formula for treating acute hepatitis and liver cirrhosis |
| 07/06/2005 | CN1209120C External applied paste as antidiarrheal |
| 07/06/2005 | CN1209114C Use of N-acetyl-D-aminoglucose in preparation of skin membrane mucosa microecologica balance regulator medicine |
| 07/06/2005 | CN1209108C Trans-dermal composition of anti-vomiting agent and preparation containing the same |
| 07/06/2005 | CN1209102C Arginine acetate oral preparation and clinical application thereof |
| 07/06/2005 | CN1209041C Nutritive agent for gastrointestinal function |
| 07/05/2005 | US6914158 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/05/2005 | US6914075 Cystine derivative and agent for suppressing activation of inflammatory factors |
| 07/05/2005 | US6914074 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer |
| 07/05/2005 | US6914059 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 07/05/2005 | US6914054 Treatment with a 1' 2' and/or 3' nucleoside or a pharmaceutically acceptable salt or prodrug; nontoxic |
| 07/05/2005 | US6913892 Method of obtaining compositions comprising Y4 specific compounds |
| 07/05/2005 | CA2309485C New 4-arylpiperidine derivatives for the treatment of pruritus |
| 07/05/2005 | CA2230082C Amide compounds and use thereof |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 07/05/2005 | CA2160128C Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 07/05/2005 | CA2064382C Pharmaceutical compounds |
| 06/30/2005 | WO2005059137A1 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 06/30/2005 | WO2005058951A1 Sugar chain-lacking hepatocyte growth factor |
| 06/30/2005 | WO2005058895A1 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo [1, 2-a] pyridine-6-carboxamide mesylate salt. |
| 06/30/2005 | WO2005058361A1 USE OF mGluR1 ANTAGONISTS FOR THE TREATMENT OF GERD |
| 06/30/2005 | WO2005058343A1 Bactericide against streptococcus mutans and streptococcus sobrinus |
| 06/30/2005 | WO2005058338A1 Use of an extract of aloysia/verbena/lippia triphylla/citriodora for treating chronic and/or inflammatory diseases |
| 06/30/2005 | WO2005058323A1 USE OF METABOTROPIC GLUTAMATE RECEPTOR 1 (mGLuR1) ANTAGONISTS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME (IBS) |
| 06/30/2005 | WO2005058322A1 USE OF METABOTROPIC GLUTAMATE RECEPTOR 1 (mGLuR1) ANTAGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS |
| 06/30/2005 | WO2005058321A1 USE OF METABOTROPIC GLUTAMATE RECEPTOR 5 (mGLuR5) ANTAGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS. |
| 06/30/2005 | WO2005039589A3 Cftr channel modulators |
| 06/30/2005 | WO2005025574A3 PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES. |
| 06/30/2005 | WO2004078217A9 Bone calcification promoter |
| 06/30/2005 | WO2004002424A8 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 06/30/2005 | WO2003064629A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/30/2005 | US20050143453 Selective preventing and therapeutic agents for progressive lesion after organic damage |
| 06/30/2005 | US20050143438 N3 alkylated benzimidazole derivatives as MEk inhibitors |
| 06/30/2005 | US20050143423 Antiulcer; antisecretory; solubility, bioavailability; slow hydrolysis; full inhibition of acid secretion in oral therapy by prolonged presence in body; 1-(carboxythiophenesulfonyl)- 2-(substituted pyridylmethylsulfinyl) benzimidazoles; also with LANSOPRAZOLE, OMEPRAZOLE, PANTOPRAZOLE, or RABEPRAZOLE |
| 06/30/2005 | US20050143405 Dipeptidyl peptidase inhibitors that lower plasma glucose; treatment and prophylaxis of diabetes, non-insulin dependent diabetes; 2-amino-3aminomethyl-4-phenylpyridines |
| 06/30/2005 | US20050143390 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/30/2005 | US20050143379 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 06/30/2005 | US20050143368 Chemical compounds |
| 06/30/2005 | US20050143337 Nucleic acid-based compounds and methods of use thereof |
| 06/30/2005 | US20050143302 Inhibiting NF-kappa B-dependent target gene expression in a cell; fusions of a NEMO binding domain and a membrane translocation domain (third helix of antennapedia homeodomain or the HIV-1 Tat protein) |
| 06/30/2005 | US20050142617 gene related to bone density; possible use in the drug screening, treatment, and diagnosis of bone disorders such as osteoporosis |
| 06/30/2005 | US20050142535 Ogligonucleotides comprising alternating segments and uses thereof |
| 06/30/2005 | US20050142227 Herbal composition for gastrointestinal disorders |
| 06/30/2005 | US20050142222 Boehmeria frutescens Thunberg, Boehmeria nivea or the nettle family extracts; without using of toxic organic solvents |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | US20050142110 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta; free of human serum albumin; stability |
| 06/30/2005 | US20050142077 Usa of an antimicrobial glass ceramic for dental care and oral hygiene |
| 06/30/2005 | US20050142076 Dental viscous pharmaceutical containing basic fibroblast growth factor |
| 06/30/2005 | CA2580663A1 Use of an extract of aloysia/verbena/lippia triphylla/citriodora for treating chronic and/or inflammatory diseases |
| 06/30/2005 | CA2550013A1 Bactericide against streptococcus mutans and streptococcus sobrinus |
| 06/30/2005 | CA2549878A1 Glycosylation-deficient hepatocyte growth factor |
| 06/30/2005 | CA2549486A1 Use of erythropoietin in the treatment of disturbances of iron distribution in chronic inflammatory intestinal diseases |
| 06/30/2005 | CA2549144A1 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo [1, 2-a] pyridine-6-carboxamide mesylate salt |
| 06/30/2005 | CA2549030A1 Tricyclic imidazopyridines for use as gastric secretion inhibitors |
| 06/30/2005 | CA2548773A1 A treatment for necrotizing enterocolitis |
| 06/30/2005 | CA2547764A1 Benzoxazine derivatives and uses thereof |
| 06/30/2005 | CA2545671A1 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 06/29/2005 | EP1548015A1 Novel crystals |
| 06/29/2005 | EP1548008A1 Compound having tgf-beta inhibitory activity and medicinal composition containing the same |
| 06/29/2005 | EP1547615A1 Remedy |
| 06/29/2005 | EP1547614A1 Medicinal composition for inhibiting the expression of atp-citrate lyase and use thereof |
| 06/29/2005 | EP1547605A1 Adsorbents for oral administration |
| 06/29/2005 | EP1547604A1 Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient |
| 06/29/2005 | EP1547598A1 NOVEL USES OF PROSTAGLANDIN D sb 2 /sb , PROSTAGLANDIN D sb 2 /sb AGONIST AND PROSTAGLANDIN D sb 2 /sb ANTAGONIST |
| 06/29/2005 | EP1547593A1 Medicinal composition |
| 06/29/2005 | EP1547588A1 Soft capsule preparation |
| 06/29/2005 | EP1547587A1 Agent for reducing side effects of diclofenac |
| 06/29/2005 | EP1546375A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 06/29/2005 | EP1546130A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 06/29/2005 | EP1546099A2 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists |
| 06/29/2005 | EP1546098A1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 06/29/2005 | EP1546087A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 06/29/2005 | EP1546084A1 2,4-dihydroxybenzoic acid derivatives |
| 06/29/2005 | EP1546083A1 Novel substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising them and processes for the preparation of them |
| 06/29/2005 | EP1545591A2 Therapeutic use for lp229, in particular for wound healing |